SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June-July 2020.

ABSTRACT:

Background

Estimating the cumulative prevalence of SARS-COV-2 will help to understand the epidemic, contagion, and immunity to COVID-19 in vulnerable populations. The objective is to determine the extent of infection in the general population and the cumulative incidence by age group.

Methods

It was carried out with a longitudinal analytical study, in the population of the Lambayeque region, located in the north of Peru. The selection was carried out in multistages (districts, area, household, and finally choosing the interviewee within the house). Seroprevalence was estimated as a positive result of the rapid test whether it was positive IgM or positive IgG. An adjustment was made for the sampling weights used.

Results

The seroprevalence found in the region was 29.5%

SUBMITTER: Diaz-Velez C 

PROVIDER: S-EPMC8034367 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature